Study of CryptiVax-1001 in Maintenance Setting for Advanced Serous Ovarian, Fallopian Tube, or Primary Peritoneal Cancer | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Study of CryptiVax-1001 in Maintenance Setting for Advanced Serous Ovarian, Fallopian Tube, or Primary Peritoneal Cancer	Adnexal Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, endocrine system disorder, female reproductive system disorder, female reproductive system neoplasm, gonadal disorder, malignant endocrine neoplasm, neoplasm, ovarian cancer, ovarian disorder	Recruiting	Phase 1	2026-08-17		NCT07665515

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Epitopea Ltd	1

10 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Beatson West of Scotland Cancer Centre	Glasgow	United Kingdom	39
Cambridge University Hospitals NHS Foundation Trust - Addenbrookes Hospital	Cambridge	United Kingdom	4
Guy's and St Thomas' NHS Foundation Trust - Guy's Hospital	London	United Kingdom	5
Lancashire Teaching Hospitals NHS Foundation Trust - Royal Preston Hospital	Preston	United Kingdom	1
Royal Marsden NHS Foundation Trust - Institute of Cancer Research	Sutton	United Kingdom	1
Royal Marsden NHS Foundation Trust - Royal Marsden Hospital	London	United Kingdom	1
St. James's University Hospital	Leeds	United Kingdom	2
The University of Edinburgh - Western General Hospital - Edinburgh Cancer Research Centre	Edinburgh	United Kingdom	1
University College London Hospitals NHS Foundation Trust - Cancer Clinical Trials Unit	London	United Kingdom	1
University Hospitals of Leicester NHS Trust -Leicester Royal Infirmary	Leicester	United Kingdom	1